PCMC
MRNA icon

Private Capital Management (Colorado)’s Moderna MRNA Stock Holding History

Private Capital Management (Colorado)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,488
Closed -$295K – 300
2024
Q2 		$295K Buy
2,488
+67
+3% +$8.48K 0.06% 115
2024
Q1 		$258K Sell
2,421
-13
-0.5% -$1.31K 0.06% 126
2023
Q4 		$242K Buy
2,434
+23
+1% +$1.93K 0.06% 126
2023
Q3 		$249K Buy
2,411
+303
+14% +$33.8K 0.07% 106
2023
Q2 		$256K Buy
2,108
+17
+0.8% +$2.27K 0.07% 103
2023
Q1 		$321K Buy
2,091
+3
+0.1% +$495 0.1% 96
2022
Q4 		$375K Sell
2,088
-957
-31% -$156K 0.12% 82
2022
Q3 		$360K Sell
3,045
-25
-0.8% -$3.79K 0.13% 86
2022
Q2 		$529K Hold
3,070
– – 0.17% 68
2022
Q1 		$529K Buy
3,070
+2,021
+193% +$340K 0.17% 68
2021
Q4 		$266K Hold
1,049
– – 0.09% 118
2021
Q3 		$404K Hold
1,049
– – 0.17% 80
2021
Q2 		$246K Buy
+1,049
New +$187K 0.11% 107

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Private Capital Management (Colorado)'s MRNA Position: Q3 2024 in Review

Private Capital Management (Colorado) sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,488 shares — an estimated $295K sold.

Private Capital Management (Colorado) first reported a position in MRNA in Q2 2021 and held it in 13 quarters. The position peaked at $529K in Q2 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Private Capital Management (Colorado) reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Private Capital Management (Colorado) sold 2,488 Moderna shares in Q3 2024, an estimated $295K.
  • Private Capital Management (Colorado) first reported a position in Moderna in Q2 2021 and held it in 13 quarters.
  • Private Capital Management (Colorado)'s Moderna position peaked at $529K in Q2 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Private Capital Management (Colorado)'s 13F filing for Q3 2024, filed 14 Nov 2024.